Open Access
Med Sci (Paris)
Volume 36, Number 5, Mai 2020
Page(s) 465 - 471
Section M/S Revues
Published online 26 May 2020
  1. Bourgeois D, Bouchard P, Mattout C. Epidemiology of periodontal status in dentate adults in France, 2002–2003. J Periodont Res 2007 ; 42 : 21–27. [Google Scholar]
  2. Kumar PS. From focal sepsis to periodontal medicine: a century of exploring the role of the oral microbiome in systemic disease. J Physiol (Lond) 2017 ; 595 : 465–476. [CrossRef] [Google Scholar]
  3. Sebbag M, Chapuy-Regaud S, Auger I, et al. Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis. Joint Bone Spine 2004 ; 71 : 493–502. [CrossRef] [PubMed] [Google Scholar]
  4. McGraw WT, Potempa J, Farley D, et al. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun 1999 ; 67 : 3248–3256. [CrossRef] [PubMed] [Google Scholar]
  5. Vossenaar ER, Zendman AJW, van Venrooij WJ, et al. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003 ; 25 : 1106–1118. [CrossRef] [PubMed] [Google Scholar]
  6. Baka Z, György B, Géher P, et al. Citrullination under physiological and pathological conditions. Joint Bone Spine 2012 ; 79 : 431–436. [CrossRef] [PubMed] [Google Scholar]
  7. Branzk N, Lubojemska A, Hardison SE, et al. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat Immunol 2014 ; 15 : 1017–1025. [CrossRef] [PubMed] [Google Scholar]
  8. Li P, Li M, Lindberg MR, et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med 2010 ; 207 : 1853–1862. [CrossRef] [PubMed] [Google Scholar]
  9. Gabarrini G, Chlebowicz MA, Vega Quiroz ME, et al. Conserved citrullinating exoenzymes in porphyromonas species. J Dent Res 2018 ; 97 : 556–562. [CrossRef] [PubMed] [Google Scholar]
  10. Gómez-Bañuelos E, Mukherjee A, Darrah E, et al. Rheumatoid arthritis-associated mechanisms of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. J Clin Med 2019 ; 8 : 1309. [Google Scholar]
  11. Potempa J Mydel P, Koziel J. The case for periodontitis in the pathogenesis of rheumatoid arthritis. Nat Rev Rheumatol 2017 ; 13 : 606–620. [CrossRef] [PubMed] [Google Scholar]
  12. Ancuta C, Iordache C, Ancuta E, et al. Rheumatoid arthritis and periodontal disease: a complex interplay, new developments in the pathogenesis of rheumatoid arthritis. Lazaros I. Sakkas, IntechOpen. doi: 10.5772/65863. [Google Scholar]
  13. Casiano-Colón A, Marquis RE. Role of the arginine deiminase system in protecting oral bacteria and an enzymatic basis for acid tolerance. Appl Environ Microbiol 1988 ; 54 : 1318–1324. [Google Scholar]
  14. Rodríguez SB, Stitt BL, Ash DE. Expression of peptidylarginine deiminase from Porphyromonas gingivalis in Escherichia coli: enzyme purification and characterization. Arch Biochem Biophys 2009 ; 488 : 14–22. [CrossRef] [PubMed] [Google Scholar]
  15. Aliko A Kamin´ska M, Bergum B, et al. Impact of Porphyromonas gingivalis peptidylarginine deiminase on bacterial biofilm formation, epithelial cell invasion, and epithelial cell transcriptional landscape. Sci Rep 2018 ; 8 : 14144. [CrossRef] [PubMed] [Google Scholar]
  16. How KY, Song KP, Chan KG. Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol 2016; 7. [PubMed] [Google Scholar]
  17. Sato K, Yukitake H, Narita Y, et al. Identification of Porphyromonas gingivalis proteins secreted by the Por secretion system. FEMS Microbiol Lett 2013 ; 338 : 68–76. [PubMed] [Google Scholar]
  18. Bielecka E, Scavenius C, Kantyka T, et al. Peptidyl arginine deiminase from Porphyromonas gingivalis abolishes anaphylatoxin C5a activity. J Biol Chem 2014 ; 289 : 32481–32487. [CrossRef] [PubMed] [Google Scholar]
  19. Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: Implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 2010 ; 62 : 2662–2672. [CrossRef] [PubMed] [Google Scholar]
  20. Stobernack T, du Espina MT, Mulder LM, et al. A Secreted bacterial peptidylarginine deiminase can neutralize human innate immune defenses. mBio 2018; 9 : e01704–18. [PubMed] [Google Scholar]
  21. Stobernack T, Glasner C, Junker S, et al. Extracellular proteome and citrullinome of the oral pathogen Porphyromonas gingivalis. J Proteome Res 2016 ; 15 : 4532–4543. [PubMed] [Google Scholar]
  22. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 2013; 5 : 178ra40–178ra40. [CrossRef] [PubMed] [Google Scholar]
  23. Wang F, Chen FF, Gao WB, et al. Identification of citrullinated peptides in the synovial fluid of patients with rheumatoid arthritis using LC-MALDI-TOF/TOF. Clin Rheumatol 2016 ; 35 : 2185–2194. [Google Scholar]
  24. Darrah E, Giles JT, Ols ML, et al. Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity. Sci Transl Med 2013; 5 : 186ra65. [CrossRef] [PubMed] [Google Scholar]
  25. Roudier J, Balandraud N, Auger I. Anti PAD autoimmunity and rheumatoid arthritis. Joint Bone Spine 2018 ; 85 : 659–661. [CrossRef] [PubMed] [Google Scholar]
  26. Chen J, Wright K, Davis JM, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med 2016 ; 8 : 43. [CrossRef] [PubMed] [Google Scholar]
  27. de Oliveira Ferreira R, de Brito Silva R, Magno MB, et al. Does periodontitis represent a risk factor for rheumatoid arthritis? A systematic review and meta-analysis. Ther Adv Musculoskelet Dis 2019; 11 : 1759720X19858514. [PubMed] [Google Scholar]
  28. Chen HH, Huang N, Chen YM, et al. Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Ann Rheum Dis 2013 ; 72 : 1206–1211. [CrossRef] [PubMed] [Google Scholar]
  29. Bae SC, Lee YH. Association between anti-Porphyromonas gingivalis antibody, anti-citrullinated protein antibodies, and rheumatoid arthritis. Z Rheumatol 2018 ; 77 : 522–532. [CrossRef] [PubMed] [Google Scholar]
  30. Bender P, Bürgin WB, Sculean A, et al. Serum antibody levels against Porphyromonas gingivalis in patients with and without rheumatoid arthritis: a systematic review and meta-analysis. Clin Oral Investig 2017 ; 21 : 33–42. [PubMed] [Google Scholar]
  31. Johansson L, Sherina N, Kharlamova N, et al. Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis. Arthritis Res Ther 2016 ; 18 : 201. [PubMed] [Google Scholar]
  32. Marchesan JT, Gerow EA, Schaff R, et al. Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Res Ther 2013 ; 15 : R186. [PubMed] [Google Scholar]
  33. Kaur S, Bright R, Proudman SM, et al. Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis. Semin Arthritis Rheum 2014 ; 44 : 113–122. [CrossRef] [PubMed] [Google Scholar]
  34. Monsarrat P, Vergnes JN, Cantagrel A, et al. Effect of periodontal treatment on the clinical parameters of patients with rheumatoid arthritis: study protocol of the randomized, controlled ESPERA trial. Trials 2013 ; 14 : 253. [PubMed] [Google Scholar]
  35. Ortiz P, Bissada NF, Palomo L, et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009 ; 80 : 535–540. [CrossRef] [PubMed] [Google Scholar]
  36. Okada M, Kobayashi T, Ito S, et al. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis. J Periodontol 2013 ; 84 : e74–e84. [PubMed] [Google Scholar]
  37. Moen K, Brun JG, Valen M, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006 ; 24 : 656–663. [PubMed] [Google Scholar]
  38. Schwenzer A, Quirke AM, Marzeda AM, et al. Association of distinct fine specificities of anti-citrullinated peptide antibodies with elevated immune responses to Prevotella intermedia in a subgroup of patients with rheumatoid arthritis and periodontitis. Arthritis Rheum (Hoboken NJ) 2017 ; 69 : 2303–2313. [CrossRef] [Google Scholar]
  39. Konig MF, Abusleme L, Reinholdt J, et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med 2016; 8 : 369ra176. [CrossRef] [PubMed] [Google Scholar]
  40. Harvey GP, Fitzsimmons TR, Dhamarpatni A, et al. SSK, et al. Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva. J Periodontal Res 2013 ; 48 : 252–261. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.